Heart Test Laboratories Stock Today

HSCSW Stock  USD 0.07  0  3.69%   

Performance

Solid

 
Weak
 
Strong

Odds Of Distress

Quite High

 
High
 
Low
Heart Test is selling for under 0.0704 as of the 29th of June 2025; that is 3.69 percent down since the beginning of the trading day. The stock's lowest day price was 0.0704. Heart Test has more than 65 % chance of experiencing financial distress in the next few years of operation. However, it had a very solid returns during the last 90 days. The performance scores are derived for the period starting the 31st of March 2025 and ending today, the 29th of June 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
15th of June 2022
Category
Healthcare
Classification
Health Care
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange.. More on Heart Test Laboratories

Moving together with Heart Stock

  0.61DH Definitive HealthcarePairCorr
  0.61CAH Cardinal HealthPairCorr

Moving against Heart Stock

  0.74LNSR LENSAR IncPairCorr
  0.72KMTS Kestra Medical TechnPairCorr
  0.61GCTK GlucoTrack Upward RallyPairCorr
  0.6FEMY FemasysPairCorr
  0.55TFX Teleflex IncorporatedPairCorr
  0.53MOH Molina HealthcarePairCorr

Heart Stock Highlights

President CEOAndrew Simpson
Thematic IdeaDrugs (View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.00210.0023
Notably Down
Slightly volatile
Gross Profit Margin0.390.61
Way Down
Slightly volatile
Total Current Liabilities2.1 MM
Sufficiently Up
Slightly volatile
Non Current Liabilities Total371.1 K390.6 K
Notably Down
Pretty Stable
Total Assets11.5 M10.9 M
Sufficiently Up
Slightly volatile
Total Current Assets8.9 M8.5 M
Sufficiently Up
Slightly volatile
Debt Levels
Heart Test can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Heart Test's financial leverage. It provides some insight into what part of Heart Test's total assets is financed by creditors.
Liquidity
Heart Test Laboratories has accumulated 1.04 M in total debt. Heart Test Laboratories has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity.

Other Non Cash Items

509,570
Heart Test Laboratories (HSCSW) is traded on NASDAQ Exchange in USA. It is located in 550 Reserve Street, Southlake, TX, United States, 76092 and employs 15 people. Heart Test is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry. Heart Test Laboratories has accumulated about 723.48 K in cash with (6.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Heart Test Probability Of Bankruptcy

Heart Test Historical Income Statement

At this time, Heart Test's Depreciation And Amortization is fairly stable compared to the past year. Total Revenue is likely to climb to about 20.5 K in 2025, whereas Interest Expense is likely to drop slightly above 242.9 K in 2025. View More Fundamentals

Heart Stock Against Markets

Heart Test Corporate Executives

Elected by the shareholders, the Heart Test's board of directors comprises two types of representatives: Heart Test inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Heart. The board's role is to monitor Heart Test's management team and ensure that shareholders' interests are well served. Heart Test's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Heart Test's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark HilzSecretary COOProfile

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.